opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanoma - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastična sredstva - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
ultracain d-s forte
raztopina za injiciranje - artikain, kombinacije
ultracain d-s forte
injekcije - artikain, kombinacije
ultracain d-s injekcije 1:200.000
raztopina za injiciranje - artikain, kombinacije
ubistesin adrenaline 40 mg/0,010 mg v 1 ml raztopina za injiciranje
sanolabor, d.d. - raztopina za injiciranje - artikain, kombinacije
perodilam 10 mg/10 mg tablete
teva pharma b.v. - amlodipin; perindopril - tableta - amlodipin 10 mg / 1 tableta perindopril6,8 mg / 1 tableta; perindopril 6,8 mg / 1 tableta - perindopril in amlodipin
perodilam 10 mg/5 mg tablete
teva pharma b.v. - amlodipin; perindopril - tableta - amlodipin 5 mg / 1 tableta perindopril6,8 mg / 1 tableta; perindopril 6,8 mg / 1 tableta - perindopril in amlodipin
perodilam 5 mg/10 mg tablete
teva pharma b.v. - amlodipin; perindopril - tableta - amlodipin 10 mg / 1 tableta perindopril3,4 mg / 1 tableta; perindopril 3,4 mg / 1 tableta - perindopril in amlodipin
perodilam 5 mg/5 mg tablete
teva pharma b.v. - amlodipin; perindopril - tableta - amlodipin 5 mg / 1 tableta perindopril3,4 mg / 1 tableta; perindopril 3,4 mg / 1 tableta - perindopril in amlodipin